# Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study

> **NCT02449330** · PHASE4 · UNKNOWN · sponsor: **National Cerebral and Cardiovascular Center, Japan** · enrollment: 936 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Teneligliptin

## Key facts

- **NCT ID:** NCT02449330
- **Lead sponsor:** National Cerebral and Cardiovascular Center, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2020-06
- **Final completion:** 2023-06
- **Target enrollment:** 936 (ESTIMATED)
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02449330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02449330, "Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02449330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*